These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 8144659)
21. Resistance to HIV protease inhibitors: a comparison of enzyme inhibition and antiviral potency. Klabe RM; Bacheler LT; Ala PJ; Erickson-Viitanen S; Meek JL Biochemistry; 1998 Jun; 37(24):8735-42. PubMed ID: 9628735 [TBL] [Abstract][Full Text] [Related]
22. Peptide aldehydes as inhibitors of HIV protease. Sarubbi E; Seneci PF; Angelastro MR; Peet NP; Denaro M; Islam K FEBS Lett; 1993 Mar; 319(3):253-6. PubMed ID: 8458418 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of HIV-1 protease by oxim derivatives. Komai T; Yagi R; Suzuki-Sunagawa H; Ishikawa Y; Kasuya A; Miyamoto S; Handa H; Nishigaki T Biochem Biophys Res Commun; 1997 Jan; 230(3):557-61. PubMed ID: 9015361 [TBL] [Abstract][Full Text] [Related]
24. Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic protease. Meek TD; Dayton BD; Metcalf BW; Dreyer GB; Strickler JE; Gorniak JG; Rosenberg M; Moore ML; Magaard VW; Debouck C Proc Natl Acad Sci U S A; 1989 Mar; 86(6):1841-5. PubMed ID: 2648384 [TBL] [Abstract][Full Text] [Related]
25. Hydrophilic peptides derived from the transframe region of Gag-Pol inhibit the HIV-1 protease. Louis JM; Dyda F; Nashed NT; Kimmel AR; Davies DR Biochemistry; 1998 Feb; 37(8):2105-10. PubMed ID: 9485357 [TBL] [Abstract][Full Text] [Related]
26. Studies of HIV-1 protease inhibitors. I. Incorporation of a reduced peptide, simple aminoalcohol, and statine analog at the scissile site of substrate sequences. Sakurai M; Sugano M; Handa H; Komai T; Yagi R; Nishigaki T; Yabe Y Chem Pharm Bull (Tokyo); 1993 Aug; 41(8):1369-77. PubMed ID: 8403085 [TBL] [Abstract][Full Text] [Related]
27. Chemical synthesis of a biotinylated derivative of the simian immunodeficiency virus protease. Purification by avidin affinity chromatography and autocatalytic activation. Tomasselli AG; Bannow CA; Deibel MR; Hui JO; Zurcher-Neely HA; Reardon IM; Smith CW; Heinrikson RL J Biol Chem; 1992 May; 267(15):10232-7. PubMed ID: 1587812 [TBL] [Abstract][Full Text] [Related]
28. Approaches to the design of effective HIV-1 protease inhibitors. Lebon F; Ledecq M Curr Med Chem; 2000 Apr; 7(4):455-77. PubMed ID: 10702619 [TBL] [Abstract][Full Text] [Related]
29. Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins. Wu X; Liu H; Xiao H; Kappes JC Virology; 1996 May; 219(1):307-13. PubMed ID: 8623547 [TBL] [Abstract][Full Text] [Related]
31. Effects of acid proteinase inhibitors on human neutrophil chemotaxis and lysosomal enzyme release. II. Bromphenacyl bromide and 1,2-epoxy-3-(p-nitrophenoxy)propane. Ackerman SK; Matter L; Douglas SD Clin Immunol Immunopathol; 1983 Feb; 26(2):213-22. PubMed ID: 6872342 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes. Sui Z; Salto R; Li J; Craik C; Ortiz de Montellano PR Bioorg Med Chem; 1993 Dec; 1(6):415-22. PubMed ID: 8087563 [TBL] [Abstract][Full Text] [Related]
33. Tyr115, gln165 and trp209 contribute to the 1, 2-epoxy-3-(p-nitrophenoxy)propane-conjugating activity of glutathione S-transferase cGSTM1-1. Chern MK; Wu TC; Hsieh CH; Chou CC; Liu LF; Kuan IC; Yeh YH; Hsiao CD; Tam MF J Mol Biol; 2000 Jul; 300(5):1257-69. PubMed ID: 10903867 [TBL] [Abstract][Full Text] [Related]
34. Human immunodeficiency virus type 1 and type 2 protease monomers are functionally interchangeable in the dimeric enzymes. Patterson CE; Seetharam R; Kettner CA; Cheng YS J Virol; 1992 Feb; 66(2):1228-31. PubMed ID: 1731102 [TBL] [Abstract][Full Text] [Related]
35. Evolution of the human immunodeficiency virus type 1 protease: effects on viral replication capacity and protease robustness. Capel E; Martrus G; Parera M; Clotet B; Martínez MA J Gen Virol; 2012 Dec; 93(Pt 12):2625-2634. PubMed ID: 22933665 [TBL] [Abstract][Full Text] [Related]
36. The HIV-1 protease as enzyme and substrate: mutagenesis of autolysis sites and generation of a stable mutant with retained kinetic properties. Mildner AM; Rothrock DJ; Leone JW; Bannow CA; Lull JM; Reardon IM; Sarcich JL; Howe WJ; Tomich CS; Smith CW Biochemistry; 1994 Aug; 33(32):9405-13. PubMed ID: 8068616 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of HIV protease activity by heterodimer formation. Babé LM; Pichuantes S; Craik CS Biochemistry; 1991 Jan; 30(1):106-11. PubMed ID: 1988010 [TBL] [Abstract][Full Text] [Related]